MolMed 504: Challenges in Cancer Immunotherapy

MOLMED 504
SLN:
1.5 credits

Spring
12:00pm
Pelton Auditorium, FHCRC

Each year, this class focuses on an important topic in medicine and science. Lectures introduce clinical and basic science background, followed by a seminar/discussion with speakers. Lectures are open to interestd parties. The post-lecture seminar/discussion is open only to enrolled students.

The topic for Spring Quarter 2018 is “Challenges in Cancer Immunotherapy” MolMed 504 is chaired by Dr. Hans-Peter Kiem, Dr. Conrad Liles and Dr. Nancy Maizels.

MolMed 504 Spring Quarter 2018 Schedule

May 3 – Aude G. Chapuis, MD
Assistant Member, Fred Hutch | Assistant Professor, UW
Harnessing the Therapeutic Potential of Genetically Modified Transferred T CellsMay 10 – Martin A. “Mac” Cheever, MD

May 10 – Martin A. “Mac” Cheever, MD
Director, Cancer Immunotherapy Trials Network | Member, Fred Hutch | Professor, Oncology, UW
The Dawn of Immune Oncology Dominance: Anti-PD1 and Anti-PD-L1 Therapy

May 17 – Cameron Turtle, MBBS, PhD
Associate Member, Clinical Research Division, Fred Hutch | Associate Professor, Oncology, UW
CD19 CAR-T Cell Immunotherapy for B Cell Malignancies

May 24 – Tina Albertson, MD, PhD
VP, Clinical Development, Juno Therapeutics
Development of Novel Cancer Therapeutics: A Career Path from Pediatric Oncologist to Industry Physician Scientist

May 31 – Michael Jensen, MD
Director, Ben Towne Center for Childhood Cancer Research, SCRI | Professor, Heme-Onc, UW | Joint Member, Fred Hutch
Engineered T Cell Immunity to Cancer

Past topics have included:

2007: Challenges in Malaria
2008: Challenges in Gene Therapy
2009: Hepatitis C Virus–A Global Pandemic
2010: Challenges in Stem Cell Research
2011: The Neurobiology of Addiction
2012: Challenges in Cancer Treatment
2013: Opportunities for innovative applications of technology to disease
2014: Challenges in HIV
2015: Sepsis – A Persistent Challenge in Critically Ill Patients
Webcasts View the Webcasts of the Challenges 2009 Lectures